Evidence map›Paper›PMID 19278895›Full record

ArticleCurrent opinion in chemical biology2009

Peroxo and oxo intermediates in mononuclear nonheme iron enzymes and related active sites.

Edward I Solomon, Shaun D Wong, Lei V Liu, Andrea Decker, Marina S Chow

Abstract read
In one paragraph

Article in Current opinion in chemical biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Impact of Secondary Sphere Hydrogen Bonds on OJournal of the American Chemical Society · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Characterization of the Earliest Intermediate of Fe-NJournal of the American Chemical Society · 2019
    Article
  13. Article
  14. HACS catalysis · 2018
    Article
  15. Article
  16. Article
  17. Metal-Assisted Oxo Atom Addition to an Fe(III) Thiolate.Journal of the American Chemical Society · 2017
    Article
  18. OBiochemistry · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Edward I SolomonDepartment of Chemistry, Stanford University, CA 94305, United States. Edward.Solomon@stanford.edu
Shaun D Wong
Lei V Liu
Andrea Decker
Marina S Chow

Funding

SPECTROSCOPIC STUDIES OF NONHEME IRON ENZYMESR01GM040392 · NIGMS · STANFORD UNIVERSITY · PI SOLOMON, EDWARD I · 1988 to 2021
$8.6M
NIGMS NIH HHS GM40392NIGMS NIH HHS R01 GM040392
6 · The paper itself

Abstract

Fe(III)OOH and Fe(IV)O intermediates have now been documented in a number of nonheme iron active sites. In this Current Opinion we use spectroscopy combined with electronic structure calculations to define the frontier molecular orbitals (FMOs) of these species and their contributions to reactivity. For the low-spin Fe(III)OOH species in activated bleomycin we show that the reactivity of this nonheme iron intermediate is very different from that of the analogous Compound 0 of cytochrome P450. For Fe(IV)O S=1 model species we experimentally define the electronic structure and its contribution to reactivity, and computationally evaluate how this would change for the Fe(IV)O S=2 intermediates found in nonheme iron enzymes.

Indexed as

Catalytic DomainEnzyme ActivationEnzymesIronNonheme Iron ProteinsQuantum TheorySpectrum AnalysisEnzymesIronNonheme Iron Proteins

Identifiers

PMID19278895
PMCPMC2676221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.